212 related articles for article (PubMed ID: 18927273)
1. Novel strategies for granulocyte colony-stimulating factor treatment of severe prolonged neutropenia suggested by mathematical modeling.
Shochat E; Rom-Kedar V
Clin Cancer Res; 2008 Oct; 14(20):6354-63. PubMed ID: 18927273
[TBL] [Abstract][Full Text] [Related]
2. Biological and clinical correlates after chemotherapy and granulocyte colony-stimulating factor administration.
Higa GM; DeVore RF; Auber ML; Lynch JP; Landreth KS
Pharmacotherapy; 1998; 18(1):1-8. PubMed ID: 9469674
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil growth factors.
Crawford J
Curr Hematol Rep; 2002 Nov; 1(2):95-102. PubMed ID: 12901130
[TBL] [Abstract][Full Text] [Related]
4. Optimal use of granulocyte-colony-stimulating factor in patients with cancer who are at risk for chemotherapy-induced neutropenia.
Cappozzo C
Oncol Nurs Forum; 2004 May; 31(3):569-76. PubMed ID: 15146222
[TBL] [Abstract][Full Text] [Related]
5. Effect of recombinant granulocyte colony-stimulating factor on blood neutrophil concentrations among patients with "idiopathic neonatal neutropenia": a randomized, placebo-controlled trial.
Juul SE; Christensen RD
J Perinatol; 2003 Sep; 23(6):493-7. PubMed ID: 13679938
[TBL] [Abstract][Full Text] [Related]
6. Glycosylated vs non-glycosylated granulocyte colony-stimulating factor (G-CSF)--results of a prospective randomised monocentre study.
Bönig H; Silbermann S; Weller S; Kirschke R; Körholz D; Janssen G; Göbel U; Nürnberger W
Bone Marrow Transplant; 2001 Aug; 28(3):259-64. PubMed ID: 11535993
[TBL] [Abstract][Full Text] [Related]
7. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia.
Hartmann LC; Tschetter LK; Habermann TM; Ebbert LP; Johnson PS; Mailliard JA; Levitt R; Suman VJ; Witzig TE; Wieand HS; Miller LL; Moertel CG
N Engl J Med; 1997 Jun; 336(25):1776-80. PubMed ID: 9187067
[TBL] [Abstract][Full Text] [Related]
9. Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia.
Scagni P; Saracco P; Timeus F; Farinasso L; Dall'Aglio M; Bosa EM; Crescenzio N; Spinelli M; Basso G; Ramenghi U
Haematologica; 1998 May; 83(5):432-7. PubMed ID: 9658728
[TBL] [Abstract][Full Text] [Related]
10. Endogenous granulocyte colony-stimulating factor (G-CSF) levels in chemotherapy-induced neutropenia and in neutropenia related with primary diseases.
Kavgaci H; Ozdemir F; Aydin F; Yavuz A; Yavuz M
J Exp Clin Cancer Res; 2002 Dec; 21(4):475-9. PubMed ID: 12636092
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of neutrophil production in normal and neutropenic animals during the response to filgrastim (r-metHu G-CSF) or filgrastim SD/01 (PEG-r-metHu G-CSF).
Lord BI; Woolford LB; Molineux G
Clin Cancer Res; 2001 Jul; 7(7):2085-90. PubMed ID: 11448927
[TBL] [Abstract][Full Text] [Related]
12. Clinical applications of granulocyte colony-stimulating factor: an update and summary.
Hübel K; Engert A
Ann Hematol; 2003 Apr; 82(4):207-13. PubMed ID: 12707722
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia.
Carlsson G; Ahlin A; Dahllöf G; Elinder G; Henter JI; Palmblad J
Br J Haematol; 2004 Jul; 126(1):127-32. PubMed ID: 15198743
[TBL] [Abstract][Full Text] [Related]
14. Neutropenia, neutrophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony-stimulating factor.
Kuritzkes DR
Clin Infect Dis; 2000 Feb; 30(2):256-60. PubMed ID: 10671324
[TBL] [Abstract][Full Text] [Related]
15. [Rational therapy with hematopoetic growth factors (G-CSF, GM-CSF) for patients in neutropenia].
Kahl C; Leithäuser M; Freund M
Dtsch Med Wochenschr; 2002 Jul; 127(27):1473-8. PubMed ID: 12098099
[No Abstract] [Full Text] [Related]
16. The clinical utility of granulocyte colony-stimulating factor: early achievements and future promise.
Morstyn G; Foote M; Perkins D; Vincent M
Stem Cells; 1994; 12 Suppl 1():213-27; discussion 227-8. PubMed ID: 7535147
[TBL] [Abstract][Full Text] [Related]
17. Additive effects of infection and neutropenia on the induction of granulocytopoietic activity in vivo.
Bönig HB; Hannen M; Lex C; Wölfel S; Banning U; Nürnberger W; Körholz D; Göbel U
Cancer; 1999 Jul; 86(2):340-8. PubMed ID: 10421271
[TBL] [Abstract][Full Text] [Related]
18. Recombinant granulocyte colony-stimulating factor (G-CSF) in infectious diseases: still a debate.
Wiedermann FJ; Mittermayr M; Hoffmann G; Schobersberger W
Wien Klin Wochenschr; 2001 Feb; 113(3-4):90-6. PubMed ID: 11253746
[TBL] [Abstract][Full Text] [Related]
19. [Protecting infection by using rhG-CSF in patients with lung cancer during chemotherapeutic courses].
Zhang S; Liu X; Fang J
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jun; 21(6):355-7. PubMed ID: 11326893
[TBL] [Abstract][Full Text] [Related]
20. [Granulocyte colony-stimulating factor in the newborn neutropenic patient].
Castillo Salinas F; Díaz de Heredia Rubio C; Salcedo Abizanda S; Ferrer Comalat A; Bastida Vila P; Ortega Aramburu JJ; Peguero Monforte G
An Esp Pediatr; 1998 Dec; 49(6):615-8. PubMed ID: 9972625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
